Cargando…

Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a

OBJECTIVES: We aimed to determine preoperative risk factors associated with pathologic T3a (pT3a) upstaging of clinical T1 (cT1) renal cell carcinomas (RCCs) and develop a novel model capable of accurately identifying those patients at high risk of harboring occult pT3a characteristics. METHODS: A r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hailang, Wang, Zhixian, Peng, Ejun, Chen, Zhiqiang, Tang, Kun, Xia, Ding
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202414/ https://www.ncbi.nlm.nih.gov/pubmed/34136403 http://dx.doi.org/10.3389/fonc.2021.679536

Ejemplares similares

Added Value of Biparametric MRI and TRUS-Guided Systematic Biopsies to Clinical Parameters in Predicting Adverse Pathology in Prostate Cancer
por: Liu, Hailang, et al.
Publicado: (2020)

Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging
por: Jeong, Seung-hwan, et al.
Publicado: (2016)

Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer
por: Tong, Yonghua, et al.
Publicado: (2021)

Predicting Prostate Cancer Upgrading of Biopsy Gleason Grade Group at Radical Prostatectomy Using Machine Learning-Assisted Decision-Support Models
por: Liu, Hailang, et al.
Publicado: (2020)

Retroperitoneoscopic nephrectomy versus open surgery for non-tuberculous pyonephrotic nonfunctioning kidney: a single-center experience
por: Wang, Xinguang, et al.
Publicado: (2021)

Machine learning-assisted decision-support models to better predict patients with calculous pyonephrosis
por: Liu, Hailang, et al.
Publicado: (2021)

The Preoperative Predictive Factors for Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma
por: Fukui, Shinji, et al.
Publicado: (2019)

A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

US "likely to upstage CERN accelerator"
por: Turney, J E
Publicado: (1984)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

Impact of pathological T3a upstaging on oncological outcomes of clinical T1 renal cell carcinoma: a meta-analysis
por: Chen, Luyao, et al.
Publicado: (2019)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
por: Weinberger, Vit, et al.
Publicado: (2019)

Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
por: Hills, Natalie, et al.
Publicado: (2021)

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma
por: Cao, Chuanzhen, et al.
Publicado: (2022)

A preoperative model to predict pT3 upstaging in clinically localized renal cell carcinoma
por: de la Barra, Carlos Calvo, et al.
Publicado: (2020)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
por: Van Wyhe, Renae D., et al.
Publicado: (2018)

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023)

The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
por: Sylman, Joanna L., et al.
Publicado: (2018)

Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance
por: Liu, Xiao, et al.
Publicado: (2021)

Predictive value of CD3(+) cells and interleukin 2 receptor in systemic inflammatory response syndrome after percutaneous nephrolithotomy
por: He, Yu, et al.
Publicado: (2022)

The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms
por: Wang, Huan, et al.
Publicado: (2022)

Prognostic value of SLC4A4 and its correlation with the microsatellite instability in colorectal cancer
por: Rui, Shaorui, et al.
Publicado: (2023)

Upstaged from cT1a-c to pT2a lung cancer, related to visceral pleural invasion patients, after segmentectomy: is it an indication to complete resection to lobectomy?
por: Lula Lukadi, Joseph, et al.
Publicado: (2023)

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer
por: Shi, Jian, et al.
Publicado: (2020)

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
por: Gao, Yuan, et al.
Publicado: (2016)

Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers
por: Su, Cheng, et al.
Publicado: (2021)

Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
por: Lu, Linbin, et al.
Publicado: (2021)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis
por: Yang, Xiao-Chuan, et al.
Publicado: (2022)

Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents
por: Yu, Zi-Kun, et al.
Publicado: (2021)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
por: Su, Hang, et al.
Publicado: (2021)

Factors related to upstaging of clinical stage T2 organ-confined bladder cancer following radical cystectomy: A multicenter study
por: El-Adawy, Mahmoud Shoukry, et al.
Publicado: (2022)

Molecular Pathological Markers Correlated With the Recurrence Patterns of Glioma
por: Ge, Shunnan, et al.
Publicado: (2021)

A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Peng, Wenjing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6eme01igif2korquf0gvjknu73